Oil Price Slide Propels Indian Stocks to Longest Weekly Winning Streak

Indian equity markets have achieved a significant milestone, recording their longest consecutive weekly winning run in seven months. Driven by a cooling crude oil market and supportive central bank signals, the Nifty 50 and BSE Sensex have successfully navigated recent geopolitical volatility to bolster investor sentiment.

Crude Oil Deflation Eases Macroeconomic Headwinds

A primary catalyst for this market rally is the significant drop in global crude prices. Brent crude fell by 1.4% to reach $72.7 per barrel, retreating to levels seen before the recent Iran-war tensions. This decline was facilitated by increased tanker movement following the initial U.S.-Iran peace deal, which eased supply concerns in the Strait of Hormuz.

For India, the world’s third-largest oil importer, lower crude prices act as a double win by easing inflation concerns and improving the current account deficit. The impact was visible in the aviation sector, where Interglobe Aviation saw its stock climb by 8.5% as investors anticipated reduced fuel costs.

Regulatory Support and RBI's Dovish Stance

Domestic policy measures and central bank communications have provided a secondary layer of support for the benchmarks. RBI Governor Sanjay Malhotra’s recent comments ruling out near-term interest rate hikes have provided much-needed clarity. Lower borrowing costs are expected to bolster corporate earnings, drive consumption, and support equity valuations in the coming quarters.

Furthermore, the banking sector showed resilience. Heavyweight financials, banks, and private lenders rose by 1.3%, 0.9%, and 1.5%, respectively, over the week. This momentum was bolstered by the RBI's decision to allow loans against foreign-currency deposits, a move designed to mobilize liquidity and attract overseas inflows.

Sectoral Performance and Emerging Risks

The market rally saw a divergence in sectoral performance. While six of the 16 major sectors posted weekly gains, the mid-cap index faced pressure, falling 1.2%. The Pharma index emerged as a standout performer, gaining 2.1% this week. This surge was driven by reports of the U.S. FDA engaging with Indian drugmakers regarding critical cancer medications, alongside a defensive shift by investors seeking sectors less exposed to El Niño risks and oil volatility.

However, it is not all smooth sailing. The metals sector logged a substantial weekly loss of 4.4%, tracking weaker global prices amid rising expectations of U.S. rate hikes in 2026. Additionally, analysts warn that a below-normal monsoon remains a near-term risk to the broader economy, though government moves—such as the removal of bond taxes for foreign investors—are expected to counteract these pressures by encouraging capital inflows.

Key Takeaways

• Extended Winning Streak: Indian benchmarks have logged their longest consecutive weekly gain in seven months, supported by falling Brent crude prices ($72.7/barrel).
• Sectoral Divergence: While aviation and pharma stocks thrived on lower input costs and regulatory news, the metals sector declined by 4.4% due to global pricing pressures.
• Policy Tailwinds: Sentiment was bolstered by the RBI's pause on rate hikes and new measures to attract foreign-currency deposits and overseas capital.